2nd Quarter - Report

ADVANCED MEDICAL TECHNOLOGY ASSN for ADVANCED MEDICAL TECHNOLOGY ASSN

Firm
Client
Income
—
Expenses
$379,194
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY11 Agriculture Appropriations bill [Elizabeth Sharp]

LobbyistCovered position, as disclosed
ELIZABETH PIKA SHARP —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Health Issues HCR

HR 1346/S.540 Medical Device Safety Act of 2009 - To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. [Elizabeth Sharp, Brett Loper, Elizabeth Kegler] Issues related to the 510(k) process for medical devices. [Elizabeth Sharp, Brett Loper, Elizabeth Kegler, Julie Cohen] Issues related to the FDA Transparency Proposal. . [Elizabeth Sharp, Brett Loper, Elizabeth Kegler, Julie Cohen] Issues related to radiation therapy and imaging services. [Elizabeth Sharp, Brett Loper, Elizabeth Kegler, Julie Cohen] Rep. Patrick Kennedy draft personalized medicine bill To secure the promise of personalized medicine for all Americans by expanding and accelerating genomics research and initiatives to improve the accuracy of disease diagnosis, increase the safety of drugs, and identify novel treatments and for other purposes. [Elizabeth Sharp] Sen. Orrin Hatch draft BETTER Patient Care Act To restructure how the FDA regulates certain advanced diagnostics [Brett Loper] Rep. Jim Matheson and Rep. Steve Buyer drug pedigree bill To establish a system of drug pedigree [Elizabeth Sharp]

LobbyistCovered position, as disclosed
JULIE D COHEN —
ELIZABETH RAYE KEGLER —
BRETT LOPER —
ELIZABETH PIKA SHARP —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 540 (111th), H.R. 1346 (111th)

Medicare/Medicaid MMM

H.R. 3590 (PL 111-148) - The Patient Protection and Affordable Care Act - issues related to the Patient-Centered Outcomes Research Institute. [Julie Cohen, Elizabeth Kegler] Issues related to health care group purchasing organizations. [Julie Cohen, Elizabeth Kegler, Brett Loper] Issues related to healthcare-acquired infections in the Medicare Inpatient Prospective Payment rule. [Elizabeth Sharp, Julie Cohen]

LobbyistCovered position, as disclosed
JULIE D COHEN —
ELIZABETH RAYE KEGLER —
BRETT LOPER —
ELIZABETH PIKA SHARP —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th)

Financial Institutions/Investments/Securities FIN

H.R.4173 Restoring American Financial Stability Act of 2010 [Elizabeth Sharp, Julie Cohen, Elizabeth Kegler, Brett Loper]

LobbyistCovered position, as disclosed
JULIE D COHEN —
ELIZABETH RAYE KEGLER —
BRETT LOPER —
ELIZABETH PIKA SHARP —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4173 (111th)

Copyright/Patent/Trademark CPT

S. 515 Patent Reform Act of 2009: A bill to amend title 35, United States Code, to provide for patent reform. [Elizabeth Sharp]

LobbyistCovered position, as disclosed
ELIZABETH PIKA SHARP —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Bills named: S. 515 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.